Luteolin-induced EGFR degradation is attributed to its inhibition of Hsp90 binding to the mutant EGF receptor, thus disrupting PI3K/Akt/mTOR pathway signaling, which ultimately leads to apoptosis of NSCLC cells. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.